Cargando…

Kallistatin - the score beats the marker

Detalles Bibliográficos
Autores principales:	Draikiwicz, Steven, Katz, Kristina, Tikotekar, Ashish, Parikh, Amay
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3672641/ https://www.ncbi.nlm.nih.gov/pubmed/23680390 http://dx.doi.org/10.1186/cc12576

Ejemplares similares

IL-10: a marker of cardiac bypass?
por: Balonze, Karen, et al.
Publicado: (2013)

Surviving sepsis bundle compliance: getting the time of the day it deserves
por: Borikar, Madhura, et al.
Publicado: (2013)

Timing of renal replacement therapy: is it when or how much?
por: Mahadeshwar, Teja, et al.
Publicado: (2013)

Mini-BAL: not a small matter
por: Sircar, Mousumi, et al.
Publicado: (2013)

Crystallization and crystallographic studies of kallistatin
por: Lin, Fang, et al.
Publicado: (2015)

Reduced Plasma Kallistatin Is Associated With the Severity of Coronary Artery Disease, and Kallistatin Treatment Attenuates Atherosclerotic Plaque Formation in Mice
por: Yao, Yuyu, et al.
Publicado: (2018)

Opposing Effects of Oxygen Regulation on Kallistatin Expression: Kallistatin as a Novel Mediator of Oxygen-Induced HIF-1-eNOS-NO Pathway
por: Chao, Julie, et al.
Publicado: (2017)

The Potential Role of Kallistatin in the Development of Abdominal Aortic Aneurysm
por: Li, Jiaze, et al.
Publicado: (2016)

Hepatorenal syndrome: one size does not fit all
por: Parikh, Amay, et al.
Publicado: (2012)

Serum kallistatin as a marker of severity of liver fibrosis in cirrhosis: A cross-sectional observational study
por: Kularaj, Seetaram Singh, et al.
Publicado: (2022)

Plasma kallistatin levels in patients with severe community-acquired pneumonia
por: Lin, Wei-Chieh, et al.
Publicado: (2013)

Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatin
por: Shiau, Ai-Li, et al.
Publicado: (2010)

Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
por: Cheng, Zhiyun, et al.
Publicado: (2015)

Kallistatin Attenuates Experimental Autoimmune Uveitis by Inhibiting Activation of T Cells
por: Muhammad, Fauziyya, et al.
Publicado: (2020)

Kallistatin prevents ovarian hyperstimulation syndrome by regulating vascular leakage
por: Huang, Jianfang, et al.
Publicado: (2022)

Chlorhexidine still has skin in the game
por: Lackey, Alexandra, et al.
Publicado: (2020)

Clostridium difficile outcomes difficult to generalize
por: Nagella, Naresh, et al.
Publicado: (2013)

Antiangiogenic and Antineuroinflammatory Effects of Kallistatin Through Interactions With the Canonical Wnt Pathway
por: Liu, Xiaochen, et al.
Publicado: (2013)

Cell surface expression of nucleolin mediates the antiangiogenic and antitumor activities of kallistatin
por: Huang, Xiao-Ping, et al.
Publicado: (2017)

Plasma kallistatin in critically ill patients with severe sepsis and septic shock
por: Lin, Wei-Chieh, et al.
Publicado: (2017)

Shock index: blunt clinical predictions
por: Li, Boning, et al.
Publicado: (2013)

Teaching central line placement: no clear window
por: Wilson, Ryan, et al.
Publicado: (2014)

Increased serum kallistatin levels in type 1 diabetes patients with vascular complications
por: Jenkins, Alicia J, et al.
Publicado: (2010)

Kallistatin treatment attenuates lethality and organ injury in mouse models of established sepsis
por: Li, Pengfei, et al.
Publicado: (2015)

Heparin Blocks the Inhibition of Tissue Kallikrein 1 by Kallistatin through Electrostatic Repulsion
por: Ma, Lina, et al.
Publicado: (2020)

Platelet membrane potential: unable to pull the plug on sepsis
por: Schaer, Daniel A, et al.
Publicado: (2014)

Selective decontamination: no oracle needed
por: Gorshein, Elan, et al.
Publicado: (2014)

Protective Role of Endogenous Kallistatin in Vascular Injury and Senescence by Inhibiting Oxidative Stress and Inflammation
por: Chao, Julie, et al.
Publicado: (2018)

Diabetes‐induced upregulation of kallistatin levels exacerbates diabetic nephropathy via RAS activation
por: Yang, Yanhui, et al.
Publicado: (2020)

Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2019)

Overexpressing Kallistatin Aggravates Experimental Autoimmune Uveitis Through Promoting Th17 Differentiation
por: Chen, Nu, et al.
Publicado: (2021)

Kallistatin limits abdominal aortic aneurysm by attenuating generation of reactive oxygen species and apoptosis
por: Krishna, Smriti Murali, et al.
Publicado: (2021)

Acute kidney injury: taking aim at colistin
por: Rashid, Shayan, et al.
Publicado: (2014)

Beat-to-Beat Continuous Blood Pressure Estimation Using Bidirectional Long Short-Term Memory Network
por: Lee, Dongseok, et al.
Publicado: (2020)

Protection Effect of Kallistatin on Carbon Tetrachloride-Induced Liver Fibrosis in Rats via Antioxidative Stress
por: Huang, Xiaoping, et al.
Publicado: (2014)

Novel Role of Kallistatin in Vascular Repair by Promoting Mobility, Viability, and Function of Endothelial Progenitor Cells
por: Gao, Lin, et al.
Publicado: (2014)

Kallistatin protects against sepsis-related acute lung injury via inhibiting inflammation and apoptosis
por: Lin, Wei-Chieh, et al.
Publicado: (2015)

Correction to: Kallistatin inhibits tumour progression and platinum resistance in high-grade serous ovarian cancer
por: Wu, Huan, et al.
Publicado: (2020)

Kallistatin exerts anti-lymphangiogenic effects by inhibiting lymphatic endothelial cell proliferation, migration and tube formation
por: Ma, Caiqi, et al.
Publicado: (2017)

Kallistatin reduces vascular senescence and aging by regulating microRNA‐34a‐SIRT1 pathway
por: Guo, Youming, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_2nls7k6v93b183pot3fp5pm1ii